Fine Organic Industries (FINEORG) Q4 25/26 earnings summary

Executive summary

• Achieved 4.3% consolidated revenue growth in FY26 to INR 2,365 crore, with PAT up 2% to INR 417 crore year-over-year; exports contributed 55% of revenue and domestic demand improved.

• Maintained strong operational performance despite global macroeconomic volatility, raw material inflation, and supply chain disruptions.

• Incorporated new subsidiaries in the US, UAE, and Thailand; acquisition of 80% in Oleofine Organics Sdn. Bhd., Malaysia, for MYR 34.2 million (INR 82.9 crore) approved to expand specialty chemicals business.

• Operates with a strong R&D focus, diversified product portfolio, and a global customer base across 110+ countries.

• Appointment of Mr. Shailendra Nadkarni as non-executive independent director for five years.

Financial highlights

• EBITDA margin for FY26 stood at 20.4% consolidated and 18.1% standalone.

• Standalone revenue grew 3% to ₹2,276 crore; consolidated revenue up 4% to ₹2,366 crore.

• Standalone PAT declined 11% to ₹346 crore; consolidated PAT rose 2% to ₹417 crore.

• Net cash position maintained with negative net debt to equity ratios.

• Standalone EPS for FY26 was Rs. 112.97, down from Rs. 127.09 in FY25; consolidated EPS was Rs. 136.03, up from Rs. 133.89.

Outlook and guidance

• Management expects flat revenue and profit growth until SEZ and U.S. plants are commissioned, with sustainable EBITDA margin targeted at 18%-20%.

• SEZ plant commissioning expected in the second half of FY28; U.S. plant Phase 1 to be completed 18-24 months after construction starts.

• Continued focus on international expansion, especially in the US and GCC regions.

• Raw material prices, especially vegetable oils, expected to remain elevated through FY27.

• No outstanding defaults on loans or debt securities as of the reporting date.